Stem Cell Preservation

The ability to preserve the cells is critical to their clinical application. It improves patient access to therapies by increasing the genetic diversity of cells available. In addition, the ability to preserve cells improves the "manufacturability" of a cell therapy product by permitting the cells to be stored until the patient is ready for administration of the therapy, permitting inventory control of products, and improving management of staffing at cell therapy facilities. Finally, the ability to preserve cell therapies improves the safety of cell therapy products by extending the shelf life of a product and permitting completion of safety and quality control testing before release of the product for use. preservation permits coordination between the manufacture of the therapy and patient care regimes.

Related conferences: International Conference on Clinical And Molecular Genetics, 28-30 November 2016 (Chicago, USA); 6th International Conference on Genomics & Pharmacogenomics, 22-24 September 2016 (Berlin, Germany); World Congress on Human Genetics, 31October – 02November 2016 (Valencia, Spain); International Conference on Genetic Counselling And Genomic Medicine, 11-12 August, 2016 (Birmingham, UK); Cell & Gene Therapy Congress, 19-21 May 2016 ( San Antonio, USA); 2015 Midwest Conference on Cell Therapy & Regenerative Medicine September 18-19 2015 (Kansas City, Missouri); 2nd Cell & Gene Therapy Conference 9-10 September 2015 (Philadelphia, United States); Cell & Gene Therapy Europe 29-30 September 2015 (Barcelona, Spain); Cell Manufacturing and  Gene Therapy Congress 2015 2-3 December 2015 (Brussels, Belgium). 

Umbilical cord tissue is able to be collected at the same time as umbilical cord blood and contains another type of stem cell called mesenchymal stem cells. Umbilical cord tissue derived MSCs are increasingly being utilized in regenerative medicine for a wide range of conditions including heart and kidney disease, ALS, MS, Alzheimer’s, wound healing and autoimmune diseases. Cord Blood is the blood that remains in the vein of the umbilical cord and placenta at the time of birth. Cord blood is rich in hematopoietic stem cells, which give rise to all the other blood cells and is the foundation of our bodies’ immune system. Cord blood stem cells are already being used to treat nearly 80 diseases, including: leukemia, lymphoma, anemia, and inherited metabolic disorders.

  • Neural stem cells
  • Embryonic stem cells
  • Dental stem cells
  • Stem cells for osteoarthritis
  • Totipotent stem cells

Related Conference of Stem Cell Preservation

October 21-22, 2019

23rd European Biotechnology Congress

Zurich, Switzerland
November 26-27, 2019

International Conference On Genomics and Molecular Biology

Lisbon | Portugal
November 26-27, 2019

International Conference on Cell and Gene Therapy

| Lisbon, Portugal
February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
March 16-17, 2020 |

12th World Congress and Expo on Cell & Stem Cell Research

Chicago, Illinois, USA

Stem Cell Preservation Conference Speakers

Recommended Sessions

Related Journals

Are you interested in